C12N 2999/00
Further aspects of viruses or vectors not covered by groups c12n2710/00 -
Official title: Further aspects of viruses or vectors not covered by groups C12N2710/00 - C12N2796/00 or C12N2800/00
C12N2999/00 (Further aspects of viruses or vectors not covered by groups c12n2710/00 -) appears on 56 US grants and 98 published applications in this corpus.
Search patents in C12N- Granted patents
- 56
- Published applications
- 98
- Assignees
- 65
- Inventors
- 201
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 3 |
| 2012 | 0 | 1 |
| 2013 | 3 | 3 |
| 2014 | 0 | 7 |
| 2015 | 0 | 12 |
| 2016 | 5 | 9 |
| 2017 | 5 | 6 |
| 2018 | 3 | 5 |
| 2019 | 6 | 6 |
| 2020 | 6 | 10 |
| 2021 | 3 | 7 |
| 2022 | 7 | 8 |
| 2023 | 8 | 5 |
| 2024 | 1 | 7 |
| 2025 | 5 | 3 |
| 2026 | 4 | 4 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Hematopoietic stem cell engraftment9 Jun 2026US 12,648,966 B2The Board of Trustees of the Leland Stanford Junior University
- Human immunodeficiency virus GP120 binding proteins24 Mar 2026US 12,583,911 B2ViiV HEALTHCARE UK (NO. 5) LIMITED
- Orthogonal Cas9 proteins for RNA-guided gene regulation and editing17 Mar 2026US 12,577,590 B2President and Fellows of Harvard College
- Circular RNA for translation in eukaryotic cells10 Mar 2026US 12,570,996 B2Massachusetts Institute of Technology
- Circular RNA for translation in eukaryotic cells30 Dec 2025US 12,509,701 B2Massachusetts Institute of Technology
- Methods and systems for engineering cells and for target validation30 Jul 2026US 2026/0218150 A1Bristol-Myers Squibb Company
- Orthogonal Cas9 Proteins for RNA-Guided Gene Regulation and Editing11 Jun 2026US 2026/0159856 A1President and Fellows of Harvard College
- Circular RNA For Translation In Eukaryotic Cells30 Apr 2026US 2026/0117252 A1Massachusetts Institute of Technology
- Circular RNA For Translation In Eukaryotic Cells19 Mar 2026US 2026/0078400 A1Massachusetts Institute of Technology
- Protein having nuclease activity, fusion proteins and uses thereof25 Dec 2025US 2025/0388934 A1Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Most cited
By later US patents
- Orthogonal Cas9 proteins for RNA-guided gene regulation and editing86US 9,587,252 B2President and Fellows of Harvard College · 2017
- Methods and compositions for the targeted modification of a genome54US 9,228,208 B2Regeneron Pharmaceuticals, Inc. · 2016
- Orthogonal Cas9 proteins for RNA-guided gene regulation and editing45US 10,329,587 B2President and Fellows of Harvard College · 2019
- Methods and compositions for the targeted modification of a mouse genome21US 9,546,384 B2Regeneron Pharmaceuticals, Inc. · 2017
- Circular RNA for translation in eukaryotic cells16US 11,203,767 B2Massachusetts Institute of Technology · 2021